Evvy is on a mission to close the gender health gap by discovering and leveraging overlooked female biomarkers, starting with the vaginal microbiome. In 2021, Evvy launched the first and only at-home vaginal microbiome test to use metagenomic sequencing to tell you what's up down there, why it matters, and what you can do about it. Insights from their test led to the expansion of Evvy's innovative vaginal health platform, which now brings together state-of-the-art testing, precision care, and proactive tracking to give women and people with vaginas the healthcare they deserve.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/27/23	$14,000,000	Series A	Amboy Street Ventures G9 Ventures General Catalyst Partners Ingeborg Investments LabCorp Left Lane Capital RH Capital Virtue	undisclosed